Hafiz Ali Ullatt (Appellant) filed an appeal against the order dated 17.01.2023, which admitted an application under Section 9 of the I&B Code filed by Translumina Therapeutics LLP & Anr. (Respondent No. 1, Operational Creditor) against Respondent No. 2 (Corporate Debtor). The Appellant settled the dues of the Respondent for Rs. 2.61 Crores (approx.) and paid the entire amount. An out-of-court settlement was reached between the parties, with the Corporate Debtor making the entire payment to the Operational Creditor. The IRP (Respondent No. 2) submitted that expenses were incurred during this period. The expenses included reimbursement for downloading financial and public documents from Karza Scan (Rs. 500), advocate fees for filing an affidavit (Rs. 8,250), and

Hafiz Ali Ullatt (Appellant) filed an appeal against the order dated 17.01.2023, which admitted an application under Section 9 of the I&B Code filed by Translumina Therapeutics LLP & Anr. (Respondent No. 1, Operational Creditor) against Respondent No. 2 (Corporate Debtor). The Appellant settled the dues of the Respondent for Rs. 2.61 Crores (approx.) and paid the entire amount. An out-of-court settlement was reached between the parties, with the Corporate Debtor making the entire payment to the Operational Creditor. The IRP (Respondent No. 2) submitted that expenses were incurred during this period. The expenses included reimbursement for downloading financial and public documents from Karza Scan (Rs. 500), advocate fees for filing an affidavit (Rs. 8,250), and